Read + Share
Nagamine H, Yashiro M, Yoshimoto N, Izumi M, et al. RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With
Low PD-L1 Expression. Anticancer Res 2023;43:4663-4672.
PMID: 37772582
|
 |
|
Nagamine H, Yashiro M, Yoshimoto N, Izumi M, et al. RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With
Low PD-L1 Expression. Anticancer Res 2023;43:4663-4672.
PMID: 37772582
|
|
|
|